News from abbott A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 23, 2020, 12:55 ET IMIP e Abbott anunciam parceria para salvar vidas de bebês e crianças

A iniciativa Little Heroes (Pequenos Heróis) da Abbott foi desenvolvida para apoiar instituições em todo o mundo e oferecer melhores opções de...


Nov 18, 2020, 09:00 ET Abbott Becomes First Anchor Sponsor of American Diabetes Association's Health Equity Now Initiative to Advance Access to Care and Technology for People with Diabetes

Today, Abbott (NYSE: ABT) and the American Diabetes Association® (ADA) announced that Abbott has become the first anchor sponsor of the Health Equity ...


Nov 16, 2020, 10:20 ET Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index (DJSI)

For the eighth consecutive year, Abbott (NYSE: ABT) has been named the industry leader in sustainability by the Dow Jones Sustainability Index...


Nov 10, 2020, 09:00 ET Abbott Announces the U.S. Launch of the IonicRF™ Generator for Use in Patients Living With Chronic Pain

Abbott (NYSE: ABT) today announced the launch of the IonicRF™ Generator – a new device recently cleared by the U.S. Food and Drug Administration to...


Nov 03, 2020, 08:00 ET El revolucionario sistema FreeStyle Libre de Abbott recibe aprobación INVIMA en Colombia, para su uso en personas sin diabetes.

Abbott anunció que el Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) aprobó el sistema FreeStyle Libre, la tecnología de...


Oct 30, 2020, 09:00 ET Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip™ Device

Abbott (NYSE: ABT), a global healthcare leader focused on creating life-changing technologies that help people lead fuller and healthier lives, has...


Oct 21, 2020, 07:30 ET Abbott Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance

Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2020. Third-quarter worldwide sales of $8.9 billion...


Oct 19, 2020, 07:15 ET Improved Mental and Physical Condition is Directly Linked to Nutrition, Study Shows

Researchers at the University of Illinois, Urbana-Champaign, Abbott (NYSE: ABT), and the U.S. Air Force Research Lab announced today the results of a ...


Oct 12, 2020, 09:00 ET Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's...


Oct 07, 2020, 08:00 ET Abbott Releases ID NOW™ COVID-19 Interim Clinical Study Results from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health

In a continuing effort to provide the facts about ID NOW to support public health interests, Abbott (NYSE: ABT) is sharing new interim clinical data...


Oct 05, 2020, 08:00 ET Abbott lança teste rápido de antígeno, portátil e fácil de usar, que pode fornecer resultados em até 15 minutos para ampliar os testes de COVID-19 no Brasil

O dispositivo de teste rápido Panbio™ COVID-19 Ag da Abbott é uma ferramenta confiável e acessível para que profissionais de saúde possam detectar...


Sep 28, 2020, 09:00 ET Abbott's FreeStyle® Libre 3 System Receives CE Mark - Features World's Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes

Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM) technology,8 announced today it has secured CE Mark (Conformité...


Sep 21, 2020, 09:02 ET Abbott Receives CE Mark for Next-Generation MitraClip™ Heart Valve Repair Device to Treat Mitral Regurgitation

Abbott (NYSE: ABT) today announced it has received CE Mark for its fourth-generation MitraClip™ Transcatheter Mitral Valve Repair System, the leading ...


Sep 21, 2020, 09:00 ET Abbott Hosts Conference Call for Third-Quarter Earnings

Abbott (NYSE: ABT) will announce its third-quarter 2020 financial results on Wednesday, Oct. 21, 2020, before the market opens. The announcement will ...


Sep 17, 2020, 11:39 ET Abbott Declares 387th Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. This marks the 387th consecutive...


Sep 17, 2020, 09:00 ET Abbott Introduces Libre Sense Glucose Sport Biosensor in Europe, World's First Glucose Biosensor Designed for Athletes

Abbott (NYSE: ABT) is introducing the world's first glucose sport biosensor,i Libre Sense Glucose Sport Biosensor, which is designed for athletes to...


Sep 14, 2020, 08:00 ET Abbott recebe aprovação da Anvisa para uso de FreeStyle Libre em mulheres com diabetes gestacional

A Abbott, empresa global de cuidados para a saúde e líder mundial em monitoramento contínuo de glicose, anuncia que a Anvisa (Agência Nacional de...


Sep 03, 2020, 09:00 ET Abbott Announces Start of Trial to Evaluate the New Esprit™ BTK Drug-Eluting Resorbable Scaffold

Abbott (NYSE: ABT) today announced the start of the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company's new Esprit™ BTK ...


Sep 01, 2020, 09:00 ET Abbott's FreeStyle® Libre 2 iCGM System Now Available to Medicare Beneficiaries

Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM),4 announced today its next-generation FreeStyle® Libre 2 integrated...


Aug 26, 2020, 18:30 ET Abbott's Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization; Mobile App Displays Test Results to Help Our Return to Daily Life; Ramping Production to 50 Million Tests a Month

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™...


Aug 04, 2020, 09:00 ET Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation

Abbott (NYSE: ABT) today announced first enrollments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from...


Jul 23, 2020, 09:00 ET Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device

Abbott (NYSE: ABT) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company's Patient...


Jul 16, 2020, 07:30 ET Abbott Reports Second-Quarter 2020 Results, Exceeds Analysts' Expectations

Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2020. Second-quarter worldwide sales of $7.3 billion...


Jul 13, 2020, 16:15 ET Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences

Abbott (NYSE: ABT) announced today it has reached an agreement with Edwards Lifesciences Corporation to settle all outstanding patent disputes...


Jul 06, 2020, 07:30 ET Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable...